Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.
The different long-chain fatty acid oxidation defects present with similar heterogeneous clinical phenotypes of different severity. Organs mainly affected comprise the heart, liver, and skeletal muscles. All symptoms are reversible with sufficient energy supply. In some long-chain fatty acid oxidation defects, disease-specific symptoms occur. Only in disorders of the mitochondrial trifunctional protein (TFP) complex, including long-chain 3-hydroxyacyl-coenzyme A (CoA) dehydrogenase (LCHAD) deficiency, neuropathy and retinopathy develop that are progressive and irreversible despite current treatment measures. In most long-chain fatty acid oxidation defects, no clear genotype-phenotype correlation exists due to molecular heterogeneity. However, some isolated mutations have been identified to be associated with only mild phenotypes, e.g., the V243A mutation in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. LCHAD deficiency is due to the prevalent homozygous 1528G>C mutation and presents with heterogeneous clinical phenotypes, suggesting the importance of other environmental and genetic factors. For some disorders, it was shown that residual enzyme activity measured in fibroblasts or lymphocytes correlated with severity of clinical phenotype. Implementation of newborn screening has significantly reduced morbidity and mortality of long-chain fatty acid oxidation defects. However, the severest forms of TFP deficiency are still highly associated with neonatal death. Newborn screening also identifies a great number of mildly affected patients who may never develop clinical symptoms throughout life. However, later-onset exercise-induced myopathic symptoms remain characteristic clinical features of long-chain fatty acid oxidation defects. Disease prevalence has increased with newborn screening.
Spiekerkoetter
Ute
U
Department of General Pediatrics, University Children's Hospital, Duesseldorf, Germany. ute.spiekerkoetter@uni-duesseldorf.de
D004734:Energy Metabolism / Q000235:genetics; D005227:Fatty Acids / Q000378:metabolism*; D005838:Genotype; D006801:Humans; D007231:Infant, Newborn; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology / Q000235:genetics / Q000401:mortality; D008928:Mitochondria / Q000201:enzymology*; D028361:Mitochondrial Diseases / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology / Q000235:genetics / Q000401:mortality; D015997:Neonatal Screening; D010084:Oxidation-Reduction; D010641:Phenotype; D012720:Severity of Illness Index
D005227:Fatty Acids
J Inherit Metab Dis. 1999 Jun;22(4):442-87
10407780
J Inherit Metab Dis. 2009 Aug;32(4):488-97
19399638
Ophthalmology. 1998 May;105(5):810-24
9593380
Pediatr Cardiol. 2003 May-Jun;24(3):295-7
12457256
Mol Genet Metab. 2008 Jan;93(1):5-6
17988913
Am J Med Genet A. 2008 Nov 15;146A(22):2925-8
18925671
Mol Genet Metab. 2009 Mar;96(3):85-90
19157942
Am J Hum Genet. 1999 Feb;64(2):479-94
9973285
Muscle Nerve. 2004 Jan;29(1):66-72
14694500
J Inherit Metab Dis. 2003;26(6):613-5
14605509
J Biol Chem. 2005 Sep 16;280(37):32309-16
16020546
PLoS One. 2009 Jul 30;4(7):e6449
19649258
Mol Genet Metab. 2007 Jun;91(2):138-47
17374501
Biochem Biophys Res Commun. 2006 Jul 21;346(1):33-7
16750164
J Neurol Sci. 1989 Sep;92(2-3):229-45
2809620
Hum Mutat. 2001 Sep;18(3):169-89
11524729
Pediatr Res. 2004 Feb;55(2):190-6
14630990
Hum Mutat. 2003 Jun;21(6):598-607
12754706
J Inherit Metab Dis. 2004;27(2):294-6
15243991
J Pediatr. 2003 Jun;142(6):684-9
12838198
Mol Genet Metab. 2005 Sep-Oct;86(1-2):124-33
16040264
Pediatrics. 2002 Jan;109(1):99-104
11773547
Mol Aspects Med. 2004 Oct-Dec;25(5-6):495-520
15363638
World J Gastroenterol. 2006 Dec 14;12(46):7397-404
17167825
Neuromuscul Disord. 2009 May;19(5):324-9
19327992
ILAR J. 2002;43(2):57-65
11917157
Mol Genet Metab. 2008 Aug;94(4):428-30
18485779
Lancet. 2007 Jan 6;369(9555):37-42
17208640
Pediatrics. 2006 Sep;118(3):1065-9
16950999
J Pediatr. 2003 Sep;143(3):335-42
14517516
J Perinat Med. 2007;35(1):76-8
17313315
Brain. 2007 Aug;130(Pt 8):2045-54
17584774
Biochem Biophys Res Commun. 2002 Oct 4;297(4):1033-42
12359260
Mol Genet Metab. 2005 Jun;85(2):108-14
15896654
Clin Genet. 2009 Aug;76(2):179-87
19780764